PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scientists identify a new target for Alzheimer's disease

2010-09-22
(Press-News.org) (CHICAGO) – Neurological researchers at Rush University Medical Center have found a new therapeutic target that can potentially lead to a new way to prevent the progression of Alzheimer's disease. The target called neutral sphingomyelinase (N-SMase) is a protein that when activated, can cause a chain of reactions in the cell leading to neuronal death and memory loss.

Results from the study funded by the National Institutes of Health and the Alzheimer's Association will be published in the September 22 issue of the Journal of Neuroscience.

"There are multiple, neurotoxic, disease-causing pathways that converge on the neutral sphingomyelinase that can cause neuronal loss in the brain of an Alzheimer's patient," said Kalipada Pahan, PhD, neurological researcher and lead investigator at Rush. "If we can stop the activation of the neutral sphingomylinase, we may be able to stop memory loss and the progression of Alzheimer's disease."

In the brain of a patient with Alzheimer's disease, two abnormal structures called plaques and tangles are prime suspects in damaging and killing nerve cells. While neurons die, other brain cells like astroglia and microglia do not die. These cells become activated and glial cell activation plays a key role in the destruction of neurons. However, the molecular mechanisms by which activated glial cells can kill neurons have been poorly understood until now.

Beta-amyloid, which is a protein fragment deposited in the brains of patients who have Alzheimer's disease, causes the activation of glial cells. Neuritic plaques are mainly composed of aggregates of beta-amyloid. When healthy nerve cells in the brain are exposed to beta-amyloid, they exhibit a number of pathological changes that are characteristic of Alzheimer's pathology.

Researchers at Rush were able to determine that the neutral sphingomyelinase is triggered by the activated brain cells and beta-amyloid. However, when the neutral sphingomyelinase was inhibited by using a small molecule inhibitor and a chemical inhibitor, the activated brain cells and beta amyloid were unable to kill neurons.

Experts tested the two inhibitors using human brain cells in a mouse model and a cell culture model.

"Understanding how the disease process works is important in identifying effective approaches to protect the brain and stop the progression of Alzheimer's disease," said Pahan. "The results of this study are very promising and our next step is to translate these findings to the clinic."

"If we can develop and test a clinical medication that can target the neutral sphingomyelinase, we may be able to halt memory loss in Alzheimer's disease patients," said Pahan.

Alzheimer's disease is an irreversible, progressive brain disease that slowly destroys memory and thinking skills, and eventually even the ability to carry out the simplest tasks. In most people with Alzheimer's, symptoms first appear after age 60.Alzheimer's disease is the most common cause of dementia among older people. Alzheimer's disease affects as many as 5.3 million Americans.

INFORMATION:

Kalipada Pahan, PhD, is the Floyd Davis Professor of Neurology at Rush University Medical Center.

END



ELSE PRESS RELEASES FROM THIS DATE:

New study indicates children and parents want science assessment for 11-year-olds

2010-09-22
At a time when new transfer arrangements mean children in Northern Ireland will no longer be formally assessed in science at age 11, researchers at Queen's University have found overwhelming support for science assessment in primary schools in England and Wales. The study, which was conducted by researchers at Queen's School of Education on behalf of the Wellcome Trust, is the first study to look at the attitudes and concerns of children and parents on the way science is assessed in primary schools in England and Wales. It is hoped the findings will be used to inform ...

OHSU research suggests compound administered during some bone marrow transplants elevates risks

2010-09-22
PORTLAND, Ore - Research conducted at Oregon Health & Science University's Vaccine and Gene Therapy Institute may spur debate about the risks associated with administering a specific compound in some forms of bone-marrow transplantation. The research is published in the current edition of Cell Host and Microbe. The VGTI research team, led by institute director Jay Nelson, Ph.D., studies human cytomegalovirus, a virus that may infect up to 80 percent of the American population. The exact percentage of infected citizens is unknown due to the fact that the virus causes minor ...

Targeted therapy triggers complex mechanism of resistance

2010-09-22
Washington, DC – In order for targeted therapies against cancer to be effective, scientists need to understand upfront what related proteins in a signaling "network" makes a cancer cell resistant to a drug and selectively target them as well, say researchers at Georgetown Lombardi Comprehensive Cancer Center and Fox Chase Cancer Center. In the September 21 issue of Science Signaling, the investigators discuss how cancer cells activate a network of pro-growth proteins that can bypass a molecule being therapeutically targeted. The researchers specifically found that many ...

The Joy of sets: For ants and trees, multiple partners are a boon

2010-09-22
GAINESVILLE, Fla. — In the complex world of ant-plant partnerships, serial monogamy can help trees maximize their evolutionary fitness, a new University of Florida study shows. Trees that sequentially partner with multi-species sets of ants produce more offspring than trees that maintain a lifelong association with any single ant — even when those sets include ant species that appear to harm the tree, said Todd Palmer, a UF biology professor. The study has broad implications because many of the world's ecosystems rely on cooperative partnerships between species, Palmer ...

Avoid swimming in interplanetary lakes

2010-09-22
Titan, one of Saturn's moons, is the only moon in the solar system with an atmosphere ― ten times denser than the atmosphere of Earth. Five years ago, the Cassini–Huygens mission to Saturn, a collaboration between the European Space Agency and NASA, sent a probe through Titan's atmosphere, revealing that Titan is home to a landscape that includes hills, valleys and most notably lakes. A researcher involved with the mission, Prof. Akiva Bar-Nun of Tel Aviv University's Department of Geophysics and Planetary Sciences, has now determined the composition of these lakes. ...

Universal, primordial magnetic fields discovered in deep space by UCLA, Caltech physicists

2010-09-22
Scientists from the California Institute of Technology and UCLA have discovered evidence of "universal ubiquitous magnetic fields" that have permeated deep space between galaxies since the time of the Big Bang. Caltech physicist Shin'ichiro Ando and Alexander Kusenko, a professor of physics and astronomy at UCLA, report the discovery in a paper to be published in an upcoming issue of Astrophysical Journal Letters; the research is currently available online. Ando and Kusenko studied images of the most powerful objects in the universe — supermassive black holes that ...

Spare the rod, spoil the child?

2010-09-22
Grabbing a child firmly by the arm, yelling and repeatedly punishing him or her may not be without long-terms risks, according to researchers from the Université de Montréal. They are studying how this harsh parenting can impair the emotional development of a child, possibly leading to anxiety disorders such as social phobia, separation anxiety and panic attacks. "Several studies have shown that coercive parenting practices are linked to anxiety," says Françoise Maheu a professor at the Université de Montréal's Department of Psychiatry and lead investigator of the study. ...

'Synthetic lethality' strategy improves molecularly targeted cancer therapy

2010-09-22
PHILADELPHIA (September 21, 2010)—Molecularly targeted therapies can reduce tumors rapidly. However, not all tumors respond to the drugs, and even those that do often develop resistance over time. Looking for a way to combat the problem of resistance, researchers at Fox Chase Cancer Center hypothesized that hitting already weakened cancer cells with a second targeted agent could kill them—but only if it was the right second agent. One well-validated molecular target for anti-cancer drugs is the epidermal growth factor receptor, or EGFR. Using a novel screening approach, ...

Results of the placement of multiple endoscopic stents for postoperative biliary strictures remains excellent after long-term follow-up

2010-09-22
OAK BROOK, Ill. – September 21, 2010 – Researchers from Italy have reported results from more than 10 years of follow-up showing that the placement of multiple endoscopic stents for the treatment of postoperative biliary strictures remains excellent with a low rate of stricture recurrence after this lengthy period of time. When strictures do recur, they can be safely and successfully retreated endoscopically. The study appears in the September issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal ...

Queen's University researchers locate impulse control center in brain

2010-09-22
Impulsive behaviour can be improved with training and the improvement is marked by specific brain changes, according to a new Queen's University study. A research team led by neuroscience PhD student Scott Hayton has pinpointed the area of the brain that controls impulsive behavior and the mechanisms that affect how impulsive behavior is learned. The findings could have a significant impact on the diagnosis and treatment of several disorders and addictions, including ADHD and alcoholism. "In the classroom, kids often blurt out answers before they raise their hand. ...

LAST 30 PRESS RELEASES:

Technology could boost renewable energy storage

Introducing SandAI: A tool for scanning sand grains that opens windows into recent time and the deep past

Critical crops’ alternative way to succeed in heat and drought

Students with multiple marginalized identities face barriers to sports participation

Purdue deep-learning innovation secures semiconductors against counterfeit chips

Will digital health meet precision medicine? A new systematic review says it is about time

Improving eye tracking to assess brain disorders

Hebrew University’s professor Haitham Amal is among a large $17 million grant consortium for pioneering autism research

Scientists mix sky’s splendid hues to reset circadian clocks

Society for Neuroscience 2024 Outstanding Career and Research Achievements

Society for Neuroscience 2024 Early Career Scientists’ Achievements and Research Awards

Society for Neuroscience 2024 Education and Outreach Awards

Society for Neuroscience 2024 Promotion of Women in Neuroscience Awards

Baek conducting air quality monitoring & simulation analysis

Albanese receives funding for scholarship grant program

Generative AI model study shows no racial or sex differences in opioid recommendations for treating pain

New study links neighborhood food access to child obesity risk

Efficacy and safety of erenumab for nonopioid medication overuse headache in chronic migraine

Air pollution and Parkinson disease in a population-based study

Neighborhood food access in early life and trajectories of child BMI and obesity

Real-time exposure to negative news media and suicidal ideation intensity among LGBTQ+ young adults

Study finds food insecurity increases hospital stays and odds of readmission 

Food insecurity in early life, pregnancy may be linked to higher chance of obesity in children, NIH-funded study finds

NIH study links neighborhood environment to prostate cancer risk in men with West African genetic ancestry

New study reveals changes in the brain throughout pregnancy

15-minute city: Why time shouldn’t be the only factor in future city planning

Applied Microbiology International teams up with SelectScience

Montefiore Einstein Comprehensive Cancer Center establishes new immunotherapy institute

New research solves Crystal Palace mystery

Shedding light on superconducting disorder

[Press-News.org] Scientists identify a new target for Alzheimer's disease